Skip to main content
. Author manuscript; available in PMC: 2011 May 9.
Published in final edited form as: Int J Androl. 2009 Nov 30;33(2):385–393. doi: 10.1111/j.1365-2605.2009.01014.x

Table 1.

Subject demographics, fertility diagnoses and day 3 FSH concentrations

Characteristic Subjects (n = 84)
Age (years)
 Mean ± SD 35.6 ± 3.9
 Range 21–44
BMI (kg/m2)
 Mean ± SD 24.0 ± 5.1
 Range 16.5–42
Race [n(%)]
 Caucasian 74 (88)
 African-American/Black 3 (4)
 Hispanic 4 (5)
 Other 3 (4)
Smoking history [n(%)]
 Never 60 (71)
 Former 21 (25)
 Current 3 (4)
SART diagnosis [n(%)]
 Female factor 29 (35)
  Endometriosis 8 (10)
  Tubal factor 7 (8)
  Diminished ovarian reserve 7 (8)
  Ovulation disorders 6 (7)
  Uterine disorders 1 (1)
 Male factor 30 (36)
 Unexplained 24 (29)
 Other 1 (1)
Day 3 FSH (IU/L)
 Mean ± SD 7.7 ± 2.3
 Range 1–15.2

BMI, body mass index; SART, Society for Assisted Reproductive Technology; FSH, follicle-stimulating hormone.